Tightly regulated Doxycycline (Dox)-inducible lentiviral vectors for human myeloprotective gene therapy: in vitro and CD34+ - xenotransplant studies

被引：0

作者：

Lachmann, N. ^{[1
,2
]}

Hillje, R. ^{[1
,2
]}

Kuhn, A. ^{[1
,2
]}

Brennig, S. ^{[1
,2
]}

Dahlmann, J. ^{[3
]}

Heinz, N. ^{[2
]}

Gruh, I. ^{[3
]}

Schiedlmeier, B. ^{[2
,3
]}

Baum, C. ^{[2
]}

Moritz, T. ^{[1
,2
]}

机构：

[1] Hannover Med Sch, REBIRTH Cluster Excellence, Reprogramming & Gene Therapy Grp, Hannover, Germany

[2] Hannover Med Sch, Inst Expt Hematol, Hannover, Germany

[3] Hannover Med Sch, Leibniz Res Labs Biotechnol & Artificial Organs L, Hannover, Germany

来源：

HUMAN GENE THERAPY | 2013年 / 24卷 / 12期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：A71 / A72

页数：2

共 50 条

[31] Gene Therapy of Canine Leukocyte Adhesion Deficiency Using Lentiviral Vectors With Human CD11b and CD18 Promoters Driving Canine CD18 Expression
Hunter, Michael J.
Tuschong, Laura M.
Fowler, Cedar J.
Bauer, Thomas R., Jr.
Burkholder, Tanya H.
Hickstein, Dennis D.
MOLECULAR THERAPY, 2011, 19 (01) : 113 - 121
[32] Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates
Sandrin, V
Boson, B
Salmon, P
Gay, W
Nègre, D
Le Grand, R
Trono, D
Cosset, FL
BLOOD, 2002, 100 (03) : 823 - 832
[33] Transduction of Human Bone Marrow CD34+Cells by a Lentiviral Vector Carrying a Modified Human Beta-Globin Gene for Sickle Cell Disease Therapy
Romero, Zulema
Urbinati, Fabrizia
Geiger, Sabine
de Assin, Rafael Ruiz
Wherley, Jennifer
Kaufman, Michael
Kuftinec, Gabriela
Cooper, Aaron
Hollis, Roger
DeOlivera, Satiro
Grooks, Gay
Kohn, Donald
MOLECULAR THERAPY, 2012, 20 : S88 - S88
[34] Lentiviral transduction of P140K MGMT into human CD34+ hematopoietic progenitors at low multiplicity of infection confers significant resistance to BG/BCNU and allows selection in vitro
Zielske, SP
Gerson, SL
MOLECULAR THERAPY, 2002, 5 (04) : 381 - 387
[35] Overexpression of gibbon ape leukemia virus (GALV) receptor (GLVR1) on human CD34+ cells increases gene transfer mediated by GALV pseudotyped vectors
Relander, T
Brun, ACM
Olsson, K
Pedersen, L
Richter, J
MOLECULAR THERAPY, 2002, 6 (03) : 400 - 406
[36] Fibronectin-facilitated gene transfer of human interferon alpha into human CD34+ hematopoietic progenitors:: Long-term expression in vitro and in SCID mice.
Quan, S
Feldman, E
Yang, L
Farley, T
Tani, K
Asano, S
Ahmed, T
Abraham, NG
BLOOD, 1998, 92 (10) : 380B - 380B
[37] Preclinical Studies for Sickle Cell Disease Gene Therapy Using Bone Marrow CD34+Cells Modified with a βAS3-Globin Lentiviral Vector
Urbinati, Fabrizia
Garcia, Zulema Romero
Geiger, Sabine
de Assin, Rafael Ruiz
Kuftinec, Gabriela
Hollis, Roger P.
De Oliveira, Satiro N.
Wherley, Jennifer
Cooper, Aaron
Townes, Tim M.
Crooks, Gay M.
Read, Elizabeth J.
Walters, Mark C.
Meiselman, Herbert J.
Coates, Thomas D.
Marder, Victor J.
Kohn, Donald B.
BLOOD, 2011, 118 (21) : 1348 - 1348
[38] Restriction of HIV-1-based lentiviral vectors in adult primary marrow-derived and peripheral mobilized human CD34+ hematopoietic stem and progenitor cells occurs prior to viral DNA integration
Daniel O. Griffin
Stephen P. Goff
Retrovirology, 13
[39] High-titer lentiviral vectors stimulate fetal calf serum-specific human CD4 T-cell responses: implications in human gene therapy
Bao, L.
Guo, H.
Huang, X.
Tammana, S.
Wong, M.
McIvor, R. S.
Zhou, X.
GENE THERAPY, 2009, 16 (06) : 788 - 795
[40] High-titer lentiviral vectors stimulate fetal calf serum-specific human CD4 T-cell responses: implications in human gene therapy
L Bao
H Guo
X Huang
S Tammana
M Wong
R S McIvor
X Zhou
Gene Therapy, 2009, 16 : 788 - 795

← 1 2 3 4 5 →